LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 20.6

Change

-0.09 (-0.43)%

Market Cap

CAD 0.21B

Volume

6.62K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.14 (-0.30%)

CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

-0.06 (-0.56%)

CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

+0.18 (+0.25%)

CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

-0.10 (-0.47%)

CAD 0.66B
HTA:CA Harvest Tech Achievers Growth ..

-0.11 (-0.58%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

-0.37 (-0.54%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.09 (-0.43%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.13 (-0.48%)

CAD 0.40B
CWW:CA iShares Global Water Common Cl..

-0.18 (-0.31%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+0.71 (+1.04%)

CAD 0.28B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.96% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.96% 89% A- 88% B+
Trailing 12 Months  
Capital Gain -4.45% 11% F 15% F
Dividend Return 3.71% 63% D 56% F
Total Return -0.74% 11% F 15% F
Trailing 5 Years  
Capital Gain -3.01% 23% F 36% F
Dividend Return 35.69% 85% B 91% A-
Total Return 32.67% 29% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 0.77% 17% F 34% F
Dividend Return 1.95% 9% A- 31% F
Total Return 1.18% 56% F 45% F
Risk Return Profile  
Volatility (Standard Deviation) 6.97% 97% N/A 85% B
Risk Adjusted Return 27.91% 23% F 41% F
Market Capitalization 0.21B 62% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.